Scoop has an Ethical Paywall
Scoop InfoPages
This InfoPage in unregistered, if this is your news page register PHARMAC for InfoPages here.
PHARMAC - Latest News [Page 2]
Funding Change Will Ensure More Consistent Emergency Care For New Zealanders
Thursday, 12 March 2026, 12:56 pm | PHARMAC
Pharmac is proposing changes to the Pharmaceutical Schedule to support the Government’s decision to shift responsibility for funding ambulance medicines from Health New Zealand and ACC to Pharmac. More >>
New Proposal Aims To Reduce Complications Following A Stem Cell Transplant
Thursday, 5 March 2026, 11:27 am | PHARMAC
Pharmac is consulting on a proposal to fund letermovir, an antiviral medicine that helps prevent cytomegalovirus (CMV) infection. More >>
Pharmac Proposes To Widen Access To Two Medicines For People With Melanoma
Tuesday, 24 February 2026, 1:51 pm | PHARMAC
Pharmac’s clinical advisors have said that using these treatments together, before surgery, and then adjusting treatment after surgery based on how well the cancer has responded, can lower the chance of melanoma coming back. More >>
Pharmac Proposes Funding New Treatments That Could Transform Early Care For People With Chronic Lymphocytic Leukaemia
Wednesday, 18 February 2026, 12:59 pm | PHARMAC
Pharmac is consulting on a change that would fund two new treatment combinations - venetoclax with ibrutinib, and venetoclax with obinutuzumab - for people with CLL. More >>
New Iron Treatment Funded For People Who Have Experienced Serious Reactions
Tuesday, 17 February 2026, 3:12 pm | PHARMAC
Approximately 100 people are expected to benefit from this treatment each year. More >>
Pharmac Seeking Feedback On Plans To Modernise The Pharmaceutical Schedule
Thursday, 12 February 2026, 2:23 pm | PHARMAC
The redevelopment project aims to make the Schedule clearer, easier to navigate, and simpler to keep up to date. More >>
Improving Access To Medicines In Rural Communities
Monday, 9 February 2026, 8:39 pm | PHARMAC
Pharmac is also funding ketamine for uncontrollable pain in people receiving palliative care in their communities. More >>
Pharmac Proposes Wider Access To A Treatment For People With A Rare Blood Cancer
Wednesday, 4 February 2026, 11:24 am | PHARMAC
Pharmac is consulting on a change that would allow brentuximab vedotin to be used as a first-line treatment option for people newly diagnosed with sALCL. If approved, the treatment would be funded from 1 April 2026. More >>
Pharmac Proposes To Fund LifeChanging Treatments For People With Cystic Fibrosis
Thursday, 22 January 2026, 1:14 pm | PHARMAC
Cystic fibrosis is a longterm condition that affects around 500 New Zealanders, including children. There is no cure, and people with the condition often have shorter lives. More >>
New Iron Treatment Proposed For People Who Have Experienced Low Phosphate Levels
Tuesday, 20 January 2026, 11:50 am | PHARMAC
Pharmac is keen to hear from patients, health professionals, pharmacists, and anyone interested in this change. More >>
Pharmac Funds Treatment For Rare Disorders
Monday, 12 January 2026, 11:54 am | PHARMAC
Clinicians have supported this decision, saying it will make access to treatment simpler for their patients. More >>
Pharmac Will Not Proceed With Proposed Changes To How It Manages The Options For Investment List
Wednesday, 17 December 2025, 11:13 am | PHARMAC
“People told us that while they understood our aim was to improve transparency, they did not want us to remove funding applications from the OFI,” says Pharmac’s Director Pharmaceuticals, Adrienne Martin. More >>
Pharmac Proposes Improved Access To Emergency Medicines In Rural And Remote Communities
Monday, 1 December 2025, 2:06 pm | PHARMAC
Pharmac is working with Health NZ, ACC, ambulance services, rural GPs, midwives, and palliative care providers to understand how the proposed changes would work in practice. More >>
Easier Access To HIV Medicines From Next Year
Thursday, 27 November 2025, 11:34 am | PHARMAC
Pharmac’s Manager Pharmaceutical Funding, Claire Pouwels, says about 3,500 people will benefit from the switch to three-month dispensing. More >>
Pharmac Proposes Funding For Rare Disorder Treatment
Wednesday, 26 November 2025, 11:14 am | PHARMAC
If approved following the public consultation, approximately 10 people with these rare disorders would benefit from access to the medicine in the first year of funding. More >>
Pharmac Proposes Funding Another ADHD Medicine To Improve Supply
Thursday, 20 November 2025, 1:06 pm | PHARMAC
If approved, the Rubifen LA (long-acting) brand of methylphenidate will be funded from 1 July 2026. More >>
Dental Treatment Proposed For Public Funding
Wednesday, 12 November 2025, 2:14 pm | PHARMAC
This follows public consultation and is expected to benefit children, and those who may find some traditional dental procedures challenging. More >>
Pharmac To Fund Five Medicines For Multiple Sclerosis, Breast Cancer, Eye Conditions, And Lung Cancer
Wednesday, 12 November 2025, 11:15 am | PHARMAC
The funding decision includes new treatments and faster-to-administer versions of existing medicines, secured through a multiproduct agreement with pharmaceutical supplier Roche. More >>
Pharmac Consults On Changes To Simplify Biologic Medicine Funding Criteria
Thursday, 6 November 2025, 2:37 pm | PHARMAC
The proposed changes aim to reduce administrative workload for clinicians, improve consistency across biologic treatments, and respond to feedback received during previous consultation. More >>
Pharmac To Change Brand Of Fulvestrant Injection For New Zealanders With Breast Cancer
Thursday, 30 October 2025, 11:53 am | PHARMAC
Faslodex will be delisted on 1 May 2026, and Fulvestrant EVER Pharma will then hold Principal Supply Status until 30 June 2028. More >>
